6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid
C37H34N14O6 — CID 159324496
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid
6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid (PubChem CID 159324496) has the molecular formula C37H34N14O6 and a molecular weight of 770.77 g/mol. Its IUPAC name is 6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid.
Molecular Properties
| Compound Name | 6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid |
|---|---|
| PubChem CID | 159324496 |
| Molecular Formula | C37H34N14O6 |
| Molecular Weight | 770.77 g/mol |
| Exact Mass | 770.28 |
| IUPAC Name | 6-[(1-cyclohexa-1,5-dien-1-yl-2-oxo-3-pyridinyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid;8-(methylamino)-6-[[1-(6-methylpyridazin-3-yl)-2-oxo-3-pyridinyl]amino]imidazo[1,2-b]pyridazine-3-carboxylic acid |
| SMILES | CNc1cc(Nc2cccn(-c3ccc(C)nn3)c2=O)nn2c(C(=O)O)cnc12.CNc1cc(Nc2cccn(C3=CCCC=C3)c2=O)nn2c(C(=O)O)cnc12 |
| InChI | InChI=1S/C19H18N6O3.C18H16N8O3/c1-20-14-10-16(23-25-15(19(27)28)11-21-17(14)25)22-13-8-5-9-24(18(13)26)12-6-3-2-4-7-12;1-10-5-6-15(23-22-10)25-7-3-4-11(17(25)27)21-14-8-12(19-2)16-20-9-13(18(28)29)26(16)24-14/h3,5-11,20H,2,4H2,1H3,(H,22,23)(H,27,28);3-9,19H,1-2H3,(H,21,24)(H,28,29) |
| InChIKey | LEEMHMKRGOFCBC-UHFFFAOYSA-N |
| XLogP | 4.03 |
| TPSA | 252.88 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 770.77 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het_6_tetrazine(18)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159324496 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.